NovaBay Pharmaceuticals Inc
NBY0.620USD
+0.026+4.47%
시장 운영 시간 （ET）시세는 15분 지연됩니다
3.61M시가총액
1.36P/E TTM
자세한 내용은 NovaBay Pharmaceuticals Inc 회사
NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
회사 정보
종목 코드 NBY
회사 이름NovaBay Pharmaceuticals Inc
상장일Oct 26, 2007
CEOMr. Justin M. Hall, Esq.
직원 수14
유형Ordinary Share
회계 연도 종료Oct 26
주소2000 Powell St Ste 1150
도시EMERYVILLE
증권 거래소NYSE American Consolidated
국가United States of America
우편 번호94608-1804
전화15108998800
웹사이트https://novabay.com/
종목 코드 NBY
상장일Oct 26, 2007
CEOMr. Justin M. Hall, Esq.
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Chief Executive Officer, Chief Compliance Officer, General Counsel, Director
Chief Executive Officer, Chief Compliance Officer, General Counsel, Director
580.00
-0.34%
Mr. Mijia (Bob) Wu
Mr. Mijia (Bob) Wu
Director
Director
122.00
--
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
92.00
--
Mr. Yongxiang (Sean) Zheng
Mr. Yongxiang (Sean) Zheng
Director
Director
50.00
--
Ms. Julie Garlikov
Ms. Julie Garlikov
Independent Director
Independent Director
50.00
--
Mr. Tommy Law
Mr. Tommy Law
Interim Chief Financial Officer, Treasurer
Interim Chief Financial Officer, Treasurer
26.00
--
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Chief Executive Officer, Chief Compliance Officer, General Counsel, Director
Chief Executive Officer, Chief Compliance Officer, General Counsel, Director
580.00
-0.34%
Mr. Mijia (Bob) Wu
Mr. Mijia (Bob) Wu
Director
Director
122.00
--
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
92.00
--
Mr. Yongxiang (Sean) Zheng
Mr. Yongxiang (Sean) Zheng
Director
Director
50.00
--
Ms. Julie Garlikov
Ms. Julie Garlikov
Independent Director
Independent Director
50.00
--
Mr. Tommy Law
Mr. Tommy Law
Interim Chief Financial Officer, Treasurer
Interim Chief Financial Officer, Treasurer
26.00
--
수익 분석
통화: USD마지막 업데이트: Sun, Jul 6
통화: USD마지막 업데이트: Sun, Jul 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
사업별USD
이름
수익
비율
Avenova
8.67M
88.67%
Other products
1.07M
10.98%
Other revenue, net
34.00K
0.35%
NeutroPhase
0.00
0.00%
지역별USD
이름
수익
비율
United States
9.78M
100.00%
사업별
지역별
사업별USD
이름
수익
비율
Avenova
8.67M
88.67%
Other products
1.07M
10.98%
Other revenue, net
34.00K
0.35%
NeutroPhase
0.00
0.00%
주식 보유 통계
마지막 업데이트: Sun, Jul 27
마지막 업데이트: Sun, Jul 27
주주
주주 유형
주주
주주
비율
Poplar Point Capital Management LLC
17.54%
Sabby Management, LLC
3.75%
C2C Wealth Management, LLC
1.68%
Geode Capital Management, L.L.C.
0.60%
XTX Markets LLC
0.34%
Other
76.08%
주주
주주
비율
Poplar Point Capital Management LLC
17.54%
Sabby Management, LLC
3.75%
C2C Wealth Management, LLC
1.68%
Geode Capital Management, L.L.C.
0.60%
XTX Markets LLC
0.34%
Other
76.08%
주주 유형
주주
비율
Hedge Fund
17.94%
Investment Advisor/Hedge Fund
4.35%
Investment Advisor
1.89%
Venture Capital
0.34%
Individual Investor
0.02%
Other
75.46%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
43
1.43M
24.54%
+213.78K
2025Q1
42
1.34M
22.96%
+376.59K
2024Q4
40
546.91K
11.19%
+390.20K
2024Q3
42
126.44K
2.60%
+79.02K
2024Q2
44
12.01K
0.89%
-33.08K
2024Q1
44
12.73K
1.48%
-22.10K
2023Q4
45
34.29K
18.48%
+25.73K
2023Q3
47
15.18K
15.11%
-444.00
2023Q2
47
9.53K
10.53%
-5.30K
2023Q1
51
13.02K
22.50%
-2.13K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Poplar Point Capital Management LLC
1.02M
17.54%
+19.91K
+1.99%
Jun 03, 2025
Sabby Management, LLC
218.04K
3.75%
+218.04K
--
Mar 31, 2025
C2C Wealth Management, LLC
55.00K
0.95%
+4.10K
+8.05%
Mar 31, 2025
Geode Capital Management, L.L.C.
35.00K
0.6%
+1.97K
+5.95%
Mar 31, 2025
XTX Markets LLC
19.85K
0.34%
+3.71K
+22.98%
Mar 31, 2025
Two Sigma Investments, LP
17.47K
0.3%
-13.94K
-44.37%
Mar 31, 2025
Susquehanna International Group, LLP
10.56K
0.18%
+10.56K
--
Mar 31, 2025
Tower Research Capital LLC
5.46K
0.09%
+6.00
+0.11%
Mar 31, 2025
UBS Financial Services, Inc.
749.00
0.01%
+749.00
--
Mar 31, 2025
Hall (Justin M)
580.00
0.01%
-2.00
-0.34%
Mar 18, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
이름
비율
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
Apr 18, 2024
Merger
35<1
Apr 18, 2024
Merger
35<1
Apr 18, 2024
Merger
35<1
Apr 18, 2024
Merger
35<1
Nov 14, 2022
Merger
35<1
Nov 14, 2022
Merger
35<1
날짜
유형
비율
Apr 18, 2024
Merger
35<1
Apr 18, 2024
Merger
35<1
Apr 18, 2024
Merger
35<1
Apr 18, 2024
Merger
35<1
Nov 14, 2022
Merger
35<1
Nov 14, 2022
Merger
35<1
Nov 14, 2022
Merger
35<1
Nov 14, 2022
Merger
35<1
